A comprehensive view of johnson & johnson services inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Samsung Bioepis settles patent litigation with J&J, paving way for US sales of plaque psoriasis treatment SB17 from February 22, 2025, upon FDA approval; Sandoz to handle commercialization

Samsung Bioepis, J&J settle all pending US patent litigation, clearing the way for commercialization of Samsung Bioepis’ SB17, a proposed biosimilar of reference medicine Stelara ustekinumab in the US

JOHNSON & JOHNSON - (8-K) - Disclosing Other Events

Johnson & Johnson Vision Care Submits Patent Application for Single Touch Contact Lens Case

J&J MedTech completes acquisition of Laminar Inc., a medical device company specializing in left atrial appendage elimination to reduce stroke risk in non-valvular atrial fibrillation patients; deal included an upfront payment of US$400.0M

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count